On January 29, 2024, Karleen Oberton, the Chief Financial Officer of Hologic Inc (NASDAQ: HOLX), executed a sale of 14,940 shares of the company, as disclosed in a recent filing with the Securities and Exchange Commission (SEC).
At the time of the insider transaction, Hologic Inc.’s shares were trading at $75, resulting in a market capitalization of $17.59 billion. The stock’s price-earnings ratio stands at 40.95, surpassing both the industry median of 27.56 and the company’s historical median price-earnings ratio.
Hologic Inc. is a leading medical technology firm specializing in the development, manufacturing, and supply of medical products for women’s health and well-being.
Over the past year, this insider has consistently sold a total of 14,940 shares and has not made any purchases of the company’s stock. The insider transaction history at Hologic Inc. reveals a consistent pattern of 0 insider buys and 8 insider sells over the same period.
Have you read?
Biggest banks in the world, as measured by total assets, 2023.
Highest-paid CEOs among Russell 3000 companies, 2023.
These Are the highest-paid CEOs among S&P 500 companies, 2023.
Ranked: The 50 Richest Celebrity Couples in the World, 2023.
The world’s wealthiest 300 cities, 2023.
Global Happiness Index: Happiest Countries In The World In 2023.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
